Literature DB >> 47632

Induction of endogenous murine C-type virus in spleen cell cultures treated with mitogens and 5-bromo-2'-deoxyuridine.

C Moroni, G Schumann, M Robert-Guroff, E R Suter, D Martin.   

Abstract

In short-term cultures of BALB/c spleen cells, treatment with a combination of 5-bromo-2'-deoxyuridine (BrdU) and either lipopolysaccharide W. Escherichia coli or concanavalin A resulted in release of C-type virus into the medium. Only lipopolysaccharide induced virus release when given alone. This could be potentiated by a combined treatment with BrdU. In contrast, phytohemagglutinin at mitogenic concentration had no effect with or without BrdU, suggesting that inducibility may vary between various mitogen-responsive spleen cell populations. In AKR mice, spontaneous virus release was detectable in nonstimulated spleen cell cultures. This could be potentiated by lipopolysaccharide, whereas no further increase occurred upon additional BrdU treatment. The induced viruses had C-type characteristics in that they contained reverse transcriptase that could be distinguished from cellular enzymes by template-primer preference experiments. Furthermore, the enzyme activities were particle-associated, banding in isopycnic sucrose gradients at 1.15-1.17 g/cm-3. The presence of C-type viruses was confirmed by electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47632      PMCID: PMC432347          DOI: 10.1073/pnas.72.2.535

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Studies of the mechanism of induction of infectious murine leukemia virus from AKR mouse embryo cell lines by 5-iododeoxyuridine and 5-bromodeoxyuridine.

Authors:  N Teich; D R Lowy; J W Hartley; W P Rowe
Journal:  Virology       Date:  1973-01       Impact factor: 3.616

2.  Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus.

Authors:  W P Rowe; J W Hartley; M R Lander; W E Pugh; N Teich
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

3.  Structural proteins of Rauscher leukemia virus and Harvey sarcoma virus.

Authors:  C Moroni
Journal:  Virology       Date:  1972-01       Impact factor: 3.616

4.  Terminal deoxynucleotidyl transferase in a case of childhood acute lymphoblastic leukemia.

Authors:  R McCaffrey; D F Smoler; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

5.  Cordycepin inhibits induction of murine leukovirus production by 5-iodo-2'-deoxyuridine.

Authors:  A M Wu; R C Ting; M Paran; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

6.  Isolation of naturally occurring viruses of the murine leukemia virus group in tissue culture.

Authors:  J W Hartley; W P Rowe; W I Capps; R J Huebner
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103

7.  Primer requirement and template specificity of the DNA polymerase of RNA tumor viruses.

Authors:  D Baltimore; D Smoler
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

8.  Mouse leukemia virus: "spontaneous" release by mouse embryo cells after long-term in vitro cultivation.

Authors:  S A Aaronson; J W Hartley; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

9.  Distinguishing reverse transcriptase of an RNA tumor virus from other known DNA polymerases.

Authors:  N C Goodman; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

10.  Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine.

Authors:  D R Lowy; W P Rowe; N Teich; J W Hartley
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

View more
  12 in total

1.  Expression of endogenous viral antigens during immune response.

Authors:  E Wecker
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

2.  Genetic analysis of induction of anti-polyadenylic acid antibodies and xenotropic type-C viruses.

Authors:  M Fischbach; P Volberding; N Talal; J Levy
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

3.  Assessment of some genetic non-MHC differences with GVHR-induced anti-listeria activity of macrophages.

Authors:  R M Zinkernagel; A Althage
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

4.  Induction of high serum levels of retroviral env gene products (gp70) in mice by bacterial lipopolysaccharide.

Authors:  I Hara; S Izui; P J McConahey; J H Elder; F C Jensen; F J Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

5.  Induction of type C virions from normal rat kidney cells by 2-deoxy-D-glucose.

Authors:  E V Prochownik; S Panem; W H Kirsten
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

6.  Lipopolysaccharide induces retroviral antigen expression in 129/J mouse lymphocytes: evidence for assembly of a defective viral particle.

Authors:  J Jongstra; C Moroni
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

7.  Anti-MHC immunity detected prior to intentional alloimmunization. III. Natural autoreactive H-2-specific antibodies.

Authors:  R Cerný-Provazník; P van Mourik; J Limpens; T Leupers; P Iványi
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

8.  Induction of cytolytic T- and B-cell responses against influenza virus infections.

Authors:  D Armerding; H Rossiter
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  Antibody directed against Friend leukemia virus stimulates DNA synthesis in a subpopulation of mouse B lymphocytes.

Authors:  C Moroni; L Forni; G Hunsmann; G Schumann
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  Endogenous retrovirus expression in stimulated murine lymphocytes. Identification of a new locus controlling mitogen induction of a defective virus.

Authors:  J P Stoye; C Moroni
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.